Results 201 to 210 of about 3,476,254 (357)
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source
Molecular Oncology, EarlyView.Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley +1 more source
Beefing up communication skills of upper-level animal science students. [PDF]
Transl Anim SciNorris-Parish SL +5 more
europepmc +1 more source
Teacher Training for Graduate Students in Animal Sciences
, 1979 William R. Boone +2 more
openalex +1 more source
Report on research and training in animal science at Sokoine University of Agriculture, Tanzania: 1969 to 1990 [PDF]
, 1993 R.L. Kurwijila, M. Mgheni
openalex +1 more source
Molecular Oncology, EarlyView.TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach +8 more
wiley +1 more source
Statistics for veterinary and animal science [PDF]
, 1999 A.S. Petrie, Paul Watson
openalex +1 more source